We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Bavarian Nordic (BVNRY) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Bavarian Nordic (BVNRY - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Bavarian Nordic is a member of our Medical group, which includes 1022 different companies and currently sits at #3 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Bavarian Nordic is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for BVNRY's full-year earnings has moved 9.6% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
According to our latest data, BVNRY has moved about 19.5% on a year-to-date basis. Meanwhile, stocks in the Medical group have gained about 4.8% on average. This means that Bavarian Nordic is outperforming the sector as a whole this year.
Another Medical stock, which has outperformed the sector so far this year, is Dare Bioscience, Inc. (DARE - Free Report) . The stock has returned 6.8% year-to-date.
The consensus estimate for Dare Bioscience, Inc.'s current year EPS has increased 89.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Bavarian Nordic belongs to the Medical - Biomedical and Genetics industry, a group that includes 503 individual stocks and currently sits at #82 in the Zacks Industry Rank. On average, this group has lost an average of 1.7% so far this year, meaning that BVNRY is performing better in terms of year-to-date returns. Dare Bioscience, Inc. is also part of the same industry.
Investors interested in the Medical sector may want to keep a close eye on Bavarian Nordic and Dare Bioscience, Inc. as they attempt to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Bavarian Nordic (BVNRY) Stock Outpacing Its Medical Peers This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Bavarian Nordic (BVNRY - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Bavarian Nordic is a member of our Medical group, which includes 1022 different companies and currently sits at #3 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Bavarian Nordic is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for BVNRY's full-year earnings has moved 9.6% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
According to our latest data, BVNRY has moved about 19.5% on a year-to-date basis. Meanwhile, stocks in the Medical group have gained about 4.8% on average. This means that Bavarian Nordic is outperforming the sector as a whole this year.
Another Medical stock, which has outperformed the sector so far this year, is Dare Bioscience, Inc. (DARE - Free Report) . The stock has returned 6.8% year-to-date.
The consensus estimate for Dare Bioscience, Inc.'s current year EPS has increased 89.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Bavarian Nordic belongs to the Medical - Biomedical and Genetics industry, a group that includes 503 individual stocks and currently sits at #82 in the Zacks Industry Rank. On average, this group has lost an average of 1.7% so far this year, meaning that BVNRY is performing better in terms of year-to-date returns. Dare Bioscience, Inc. is also part of the same industry.
Investors interested in the Medical sector may want to keep a close eye on Bavarian Nordic and Dare Bioscience, Inc. as they attempt to continue their solid performance.